Award
National Institute of Allergy and Infectious Diseases 5R21AI181894-02
Developing Selective Inhibitors and Probes for Concentrative Nucleoside Transporters
Recipient
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
Award Amount
$176,196.00
Ceiling
$176,196.00
Awarded
July 18, 2025
Identifier
5R21AI181894-02
NIH grant awarded to Rosalind Franklin University of Medicine & Science for research on selective inhibitors and probes targeting nucleoside transporters related to HIV/AIDS. The project includes design, synthesis, biological testing, and ADMET studies.
Description
This is a NIH grant project for developing inhibitors and probes for nucleoside transporters, with a focus on HIV/AIDS related research. The project involves multidisciplinary approaches including structure-based design, synthesis, biological assays, and ADMET studies. The project duration is from August 1, 2024, to June 30, 2027.